Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| STERIS plcSTE · Entity 3228 | Sr. V.P., Procedural Solutions | May 31, 2019 | June 03, 2019 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
STERIS plc
Report date May 31, 2019 · Filed June 03, 2019
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 14,685 |
Reported balance
After 2019-05-31 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2019-05-31 · Grant · Acquired 1,112 · Balance 14,685 F1: All 1,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2022 and 278 on May 31, 2023. F2: 9,976 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021; 1,864 on May 31, 2022; 834 on May 31, 2022; and 278 on May 31, 2023. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $147.05 · Expires 2029-05-31 | Direct | 19,244 |
Reported balance
After 2019-05-31 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-05-31 · Grant · Acquired 19,244 · Balance 19,244 F3: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. |
Filing footnotes · ownership attribution and instrument terms
F1: All 1,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2022 and 278 on May 31, 2023.
F2: 9,976 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021; 1,864 on May 31, 2022; 834 on May 31, 2022; and 278 on May 31, 2023.
F3: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 1
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 15,864 · Balance 0 F1: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $65.05 · Expires 2025-08-27 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 11,700 · Balance 0 F3: This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 11,700 ordinary shares of STERIS for $65.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2026-06-01 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F4: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.07 · Expires 2027-05-30 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 15,000 · Balance 0 F5: This option becomes exercisable as follows: 3,750 on May 30, 2018; 3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.22 · Expires 2028-05-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 20,536 · Balance 0 F6: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
Filing footnotes · ownership attribution and instrument terms
F1: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022.
F2: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F3: This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 11,700 ordinary shares of STERIS for $65.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option becomes exercisable as follows: 3,750 on May 30, 2018; 3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 31, 2019 Filed Jun 3, 2019 20:40 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 19,244 | $0.00 Strike: $147.05 | $0.00 |
DisclosureSEC source: 0001209191-19-033944 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,244 Underlying: Ordinary Shares · 19,244 shares Expires 2029-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 4,811 on June 1, 2020; 4,811 on June 1, 2021; 4,811 on May 31, 2022 and 4,811 on May 31, 2023. Read SEC document |
| May 31, 2019 Filed Jun 3, 2019 20:40 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 1,112 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-033944 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,685 F1 · shares: All 1,112 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 834 on May 31, 2022 and 278 on May 31, 2023. F2 · balance_after: 9,976 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021; 1,864 on May 31, 2022; 834 on May 31, 2022; and 278 on May 31, 2023. Read SEC document |
| May 28, 2019 Filed May 30, 2019 20:32 UTC | STERIS plc STE · Entity 3228 | Tax withholdingOrdinary Shares | 2,291 | $133.92 | $306,810.72 |
DisclosureSEC source: 0001209191-19-033440 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,573 F1 · shares: 2,291 shares were withheld from the 7,000 restricted shares that vested on May 28, 2019. These 2,291 ordinary shares represent the value of the taxes required to be withheld pursuant to applicable employment or tax laws, as determined by the Issuer. These 7,000 ordinary shares were awarded to Mr. Khan on August 27, 2015. These vested shares were valued at the NYSE closing market price on May 28, 2019. F2 · balance_after: 8,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 20,536 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 5 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,536 Underlying: Ordinary Shares · 20,536 shares Expires 2028-05-31 F6 · price: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was received under the Scheme in exchange for an option to purchase 20,536 STERIS ordinary shares for $114.22 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 4 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2027-05-30 F5 · price: This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on May 30, 2018;3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $77.07 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 3 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F4 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was received under the Scheme in exchange for an option to purchase 15,000 STERIS ordinary shares for $69.72 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC | STERIS plc STE · Entity 3228 | GrantEmployee Stock Option (right to buy) · Derivative | 11,700 | Not disclosed Strike: $65.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,700 Underlying: Ordinary Shares · 11,700 shares Expires 2025-08-27 F3 · price: This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option become exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was received under the Scheme in exchange for an option to purchase 11,700 STERIS ordinary shares for $65.05 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:28 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 15,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021602 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,864 F1 · shares: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F1 · balance_after: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:52 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 20,536 | Not disclosed Strike: $114.22 | Not disclosed |
DisclosureSEC source: 0001209191-19-021560 · doc4.xml · derivative · entry 5 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 20,536 shares Expires 2028-05-31 F6 · price: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. This option was assumed by STERIS under the Scheme and converted to an option to purchase 20,536 ordinary shares of STERIS for $114.22 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:52 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $77.07 | Not disclosed |
DisclosureSEC source: 0001209191-19-021560 · doc4.xml · derivative · entry 4 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2027-05-30 F5 · price: This option becomes exercisable as follows: 3,750 on May 30, 2018; 3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on May 30, 2018; 3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $77.07 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:52 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $69.72 | Not disclosed |
DisclosureSEC source: 0001209191-19-021560 · doc4.xml · derivative · entry 3 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 15,000 shares Expires 2026-06-01 F4 · price: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on June 1, 2017; 3,750 on June 1, 2018; 3,750 on June 3, 2019 and 3,750 on June 1, 2020. This option was assumed by STERIS under the Scheme and converted to an option to purchase 15,000 ordinary shares of STERIS for $69.72 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:52 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerEmployee Stock Option (right to buy) · Derivative | 11,700 | Not disclosed Strike: $65.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021560 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 11,700 shares Expires 2025-08-27 F3 · price: This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 11,700 ordinary shares of STERIS for $65.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option becomes exercisable as follows: 2,925 on May 28, 2016; 2,925 on May 28, 2017; 2,925 on May 28, 2018 and 2,925 on May 28, 2019. This option was assumed by STERIS under the Scheme and converted to an option to purchase 11,700 ordinary shares of STERIS for $65.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 09:52 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 15,864 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021560 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · shares: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. F2 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 16:51 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 20,536 | $0.00 Strike: $114.22 | $0.00 |
DisclosureSEC source: 0001209191-18-034728 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,536 Underlying: Ordinary Shares · 20,536 shares Expires 2028-05-31 F3 · derivative.exercise_date: This option becomes exercisable as follows: 5,134 on May 31, 2019; 5,134 on June 1, 2020; 5,134 on June 1, 2021 and 5,134 on May 31, 2022. Read SEC document |
| May 31, 2018 Filed Jun 1, 2018 16:51 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 1,864 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-034728 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,864 F1 · shares: All 1,864 of these Common Shares are restricted. The restrictions on these Common Shares lapse as follows: 1,864 on May 31, 2022. F2 · balance_after: All 15,864 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020; 4,500 on June 1, 2021 and 1,864 on May 31, 2022. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:40 UTC | STERIS plc STE · Entity 158792 | GrantEmployee Stock Option (right to buy) · Derivative | 15,000 | $0.00 Strike: $77.07 | $0.00 |
DisclosureSEC source: 0001209191-17-036808 · doc4.xml · derivative · entry 2 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires 2027-05-30 F3 · derivative.exercise_date: This option becomes exercisable as follows: 3,750 on May 30, 2018; 3,750 on May 30, 2019; 3,750 on June 1, 2020 and 3,750 on June 1, 2021. Read SEC document |
| May 30, 2017 Filed Jun 1, 2017 16:40 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 4,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-036808 · doc4.xml · nonDerivative · entry 1 Khan Gulam Amjad · CIK 0001651656 · Sr. V.P., Procedural Solutions 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 F1 · shares: All 4,500 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 4,500 on June 1, 2021. F2 · balance_after: All 14,000 of these ordinary shares are restricted. The restrictions on these ordinary shares lapse as follows: 7,000 on May 28, 2019; 2,500 on June 1, 2020 and 4,500 on June 1, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.